Erminia Massarelli
Division Chief · University of Texas Health Science Center at Tyler
Credentials: · · · · · ·
History
- 2013–2015
Research
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1,255 citations
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 922 citations
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021
Journal of the National Comprehensive Cancer Network · 2021 · 813 citations
- RS
41 papers
30 papers · 1 as a resident
- MK
16 papers
- SS
13 papers
- VV
13 papers
- RH
12 papers
11 papers
11 papers
Grants
- 1997–2027
National Cancer Institute · P30
Project lead · $740.6K · Beckman Research Institute/City of Hope
Clinical trials
- 2023–2027
CISH Inactivated TILs in the Treatment of NSCLC
Principal investigator · Withdrawn · Phase 1, Phase 2
Intima Bioscience, Inc.
- 2022–2027
Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer
Principal investigator · Active not recruiting · Phase 1
City of Hope Medical Center
- 2006–2016
BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
- 2019–2033
Site PI · Recruiting · Phase 1, Phase 2
Inhibrx Biosciences, Inc